Restoring the Treg cell to Th17 cell ratio may alleviate HBVrelated acute-on-chronic liver failure

World Journal of Gastroenterology

Volumn 19, Issue 26, 2013, Pages 4146-4154

  Niu, Ying Hua ^a   Yin, Dong Lin ^b   Liu, Hong Li ^a   Yi, Rui Tian ^a   Yang, Yu Cong ^a   Xue, Hong An ^a   Chen, Tian Yan ^a   Zhang, Shu Lin ^a   Lin, Shu Mei ^a   Zhao, Ying Ren ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Acute on chronic liver failure; Hepatitis B virus; Regulatory T cells; T helper 17 cells; Treg cell to Th17 cell ratio

Indexed keywords

BILIRUBIN; CREATININE; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 17; TRANSCRIPTION FACTOR FOXP3; VIRUS DNA;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ANTICOAGULATION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH17 CELL;

EID: 84880091690     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i26.4146     Document Type: Article

References (36)

1. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R, Komolmit P, Lau GK, Liu Q, Madan K, Mohamed R, Ning Q, Rahman S, Rastogi A, Riordan SM, Sakhuja P, Samuel D, Shah S, Sharma BC, Sharma P, Takikawa Y, Thapa BR, Wai CT, Yuen MF. Acuteon-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009; 3: 269-282 [PMID: 19669378 DOI: 10.1007/ s12072-008-9106-x]
2. Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif 2002; 20: 252-261 [PMID: 11867872 DOI: 10.1159/000047017]
3. Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, Kumar A. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology 2011; 53: 774-780 [PMID: 21294143 DOI: 10.1002/hep.24109]
4. Chen T, He Y, Liu X, Yan Z, Wang K, Liu H, Zhang S, Zhao Y. Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-onchronic liver failure. Clin Exp Med 2012; 12: 159-164 [PMID: 22002708 DOI: 10.1007/s10238-011-0160-7]
5. Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, Sakhuja P, Sarin SK. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 2012; 142: 505-512. e1 [PMID: 22119930]
6. Bahirwani R, Shaked O, Bewtra M, Forde K, Reddy KR. Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes. Transplantation 2011; 92: 952-957 [PMID: 21869735 DOI: 10.1097/ TP.0b013e31822e6eda]
7. Du WB, Li LJ, Huang JR, Yang Q, Liu XL, Li J, Chen YM, Cao HC, Xu W, Fu SZ, Chen YG. Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc 2005; 37: 4359-4364 [PMID: 16387120 DOI: 10.1016/j. transproceed.2005.11.044]
8. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001; 34: 1225-1241 [PMID: 11732013 DOI: 10.1053/ jhep.2001.29401]
9. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2: 395-403 [PMID: 12127351 DOI: 10.1016/S1473-3099(02)00315-8]
10. Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis 2002; 2: 43-50 [PMID: 11892495 DOI: 10.1016/S1473-3099(01)00172-4]
11. Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghöner A, Vidacek D, Siewert E, Bach J, Geier A, Purucker EA, Gressner AM, Matern S, Lammert F. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol 2005; 42: 195-201 [PMID: 15664244 DOI: 10.1016/ j. jhep.2004.10.019]
12. Ambrosino G, Naso A, Feltracco P, Carraro P, Basso SM, Varotto S, Cillo U, Zanus G, Boccagni P, Brolese A, Plebani M, Giron G, D'Amico DF. Cytokines and liver failure: modification of TNF-and IL-6 in patients with acute on chronic liver decompensation treated with Molecular Adsorbent Recycling System (MARS). Acta Biomed 2003; 74 Suppl 2: 7-9 [PMID: 15055025]
13. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32: 734-739 [PMID: 11003617 DOI: 10.1053/jhep.2000.17687]
14. Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, Fu JL, Shi F, Shi M, Wang HF, Wang FS. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51: 81-91 [PMID: 19842207 DOI: 10.1002/hep.23273]
15. Ye Y, Xie X, Yu J, Zhou L, Xie H, Jiang G, Yu X, Zhang W, Wu J, Zheng S. Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. J Clin Immunol 2010; 30: 546-555 [PMID: 20393789 DOI: 10.1007/s10875-010-9416-3]
16. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3: 253-257 [PMID: 12658273 DOI: 10.1038/nri1032]
17. Reiner SL. Development in motion: helper T cells at work. Cell 2007; 129: 33-36 [PMID: 17418783 DOI: 10.1016/ j. cell.2007.03.019]
18. Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X, Tang Z, Fu YX, Wang FS. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177: 739-747 [PMID: 16785573]
19. Niu Y, Liu H, Yin D, Yi R, Chen T, Xue H, Zhang S, Lin S, Zhao Y. The balance between intrahepatic IL-17(+) T cells and Foxp3(+) regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol 2011; 12: 47 [PMID: 21851644 DOI: 10.1186/1471-2172-12-47]
20. Zhai S, Zhang L, Dang S, Yu Y, Zhao Z, Zhao W, Liu L. The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure. Viral Immunol 2011; 24: 303-310 [PMID: 21721931 DOI: 10.1089/ vim.2010.0135]
21. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470 [PMID: 11172350 DOI: 10.1053/jhep.2001.22172]
22. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008; 453: 236-240 [PMID: 18368049 DOI: 10.1038/nature06878]
23. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238 [PMID: 16648838 DOI: 10.1038/nature04753]
24. Ziegler SF, Buckner JH. FOXP3 and the regulation of Treg/ Th17 differentiation. Microbes Infect 2009; 11: 594-598 [PMID: 19371792 DOI: 10.1016/j. micinf.2009.04.002]
25. Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol 2010; 40: 1830-1835 [PMID: 20583029 DOI: 10.1002/eji.201040391]
26. Weaver CT, Hatton RD. Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol 2009; 9: 883-889 [PMID: 19935807]
27. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317: 256-260 [PMID: 17569825 DOI: 10.1126/science.1145697]
28. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141 [PMID: 16200068 DOI: 10.1038/ni1261]
29. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132 [PMID: 16200070 DOI: 10.1038/ni1254]
30. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212: 8-27 [PMID: 16903903 DOI: 10.1111/j.0105-2896.2006.00427. x]
31. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345-350 [PMID: 17375096 DOI: 10.1038/ni0407-345]
32. Jaffar Z, Ferrini ME, Girtsman TA, Roberts K. Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways. Eur J Immunol 2009; 39: 3307-3314 [PMID: 19830731 DOI: 10.1002/eji.200939498]
33. Yang J, Yang X, Zou H, Chu Y, Li M. Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus. Rheumatology (Oxford) 2011; 50: 1366-1372 [PMID: 21489974 DOI: 10.1093/ rheumatology/ker116]
34. Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, Garcia-Tsao G, Arroyo V, Kamath PS. Acute-on chronic liver failure. J Hepatol 2012; 57: 1336-1348 [PMID: 22750750 DOI: 10.1016/ j. jhep.2012.06.026]
35. Cui YL, Yan F, Wang YB, Song XQ, Liu L, Lei XZ, Zheng MH, Tang H, Feng P. Nucleoside analogue can improve the longterm prognosis of patients with hepatitis B virus infectionassociated acute on chronic liver failure. Dig Dis Sci 2010; 55: 2373-2380 [PMID: 20512414 DOI: 10.1007/s10620-010-1257-7]
36. Zhang JY, Song CH, Shi F, Zhang Z, Fu JL, Wang FS. Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment. PLoS One 2010; 5: e13869 [PMID: 21079784 DOI: 10.1371/journal. pone.0013869]